Cancer Research UK logo.
SearchDonate
  • Search

A study looking at immunotherapy before surgery for gestational trophoblastic tumour (RESOLVE)

Overview

Cancer types:

Gestational trophoblastic disease (GTD)

Status:

Open

Phase:

Phase 2

Details

This study is looking at the immunotherapy drug pembrolizumab before surgery for that has not spread.

It is for people who:

  • have had surgery to try and remove a but it hasn’t completely gone and

  • have now developed a type of gestational trophoblastic tumour which is cancer and

  • are going to have surgery again to try and remove the cancer

Recruitment start: 14 February 2024

Recruitment end: 31 August 2025

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Ehsan Ghorani

Supported by

Cancer Research UK

Cancer Research UK Imperial Centre: Clinical Trials Section

Imperial College London

NIHR Imperial Biomedical Research Centre

Last reviewed: 30 Jan 2025

CRUK internal database number: 18763

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.